| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.075 | 0.2 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |